drugset / Trial / NCT03965208
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate heparin as compared to bivalirudin for systemic anticoagulation in adult patients that require extracorporeal membrane oxygenation (ECMO). Half of the participants will receive heparin and half will receive bivalirudin.
Timeline
- Start
- 2019-05-23
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bivalirudin | Peptide | — | — |
| Comparator | HEPARIN CALCIUM | Other / unclassified | — | — |
Indications
No indication recorded.